Terumo : Announces Voting Results for the Election of Directors

June 27, 2017

Terumo Announces Voting Results for the Election of Directors

TOKYO, JAPAN - June 27, 2017 - Terumo Corporation (TSE: 4543) hereby announces the voting results for the election of directors at its Annual General Meeting of Shareholders held on June 27, 2017 in Tokyo. All candidates listed on May 10 were elected as directors of Terumo Corporation.

1. Directors (excluding directors who serve as Audit/Supervisory Committee Members)

   Name	New position	Former position
   Takayoshi Mimura	Chairman of the Board	Same as on the left
   Shinjiro Sato	President and CEO	Same as on the left
   Toshiaki Takagi	Director and Managing Executive Officer	Same as on the left
   Shoji Hatano	Director and Managing Executive Officer	Same as on the left
   Hideo Arase	Director and Senior Executive Officer	Same as on the left
   David Perez	Director and Senior Executive Officer	Same as on the left
   Ikuo Mori	Independent Director	Same as on the left
   Ryuzo Ueda	Independent Director	Same as on the left

2. Directors who serve as Audit/Supervisory Committee Members

Name	New position	Former position
Yoshihiro Kimura	Director who serves as an Audit/Supervisory Committee Member	Advisor
Toshihiko Matsumiya	Independent director who serves as an Audit/Supervisory Committee Member	Same as on the left
Masatake Yone	Independent director who serves as an Audit/Supervisory Committee Member	Same as on the left

About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over

$5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol , or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

###